American Vanguard (NYSE:AVD) Director Keith Rosenbloom Sells 556,580 Shares of Stock

American Vanguard Corporation (NYSE:AVD) Director Keith Rosenbloom sold 556,580 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $2.20, for a total transaction of $1,224,476.00. Following the transaction, the director directly owned 15,201 shares of the company’s stock, valued at approximately $33,442.20. This trade represents a 97.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

American Vanguard Trading Down 5.1%

Shares of American Vanguard stock traded down $0.12 on Thursday, reaching $2.23. The company had a trading volume of 273,132 shares, compared to its average volume of 322,056. The firm’s 50 day moving average price is $2.58 and its two-hundred day moving average price is $3.12. The firm has a market cap of $65.78 million, a PE ratio of -1.17 and a beta of 1.43. American Vanguard Corporation has a 52-week low of $2.03 and a 52-week high of $5.92. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.40 and a current ratio of 2.47.

American Vanguard (NYSE:AVD) last issued its quarterly earnings data on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.43). The company had revenue of $116.75 million during the quarter, compared to analyst estimates of $135.00 million. American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.

Institutional Trading of American Vanguard

Several hedge funds have recently made changes to their positions in the business. Potomac Capital Management Inc. purchased a new stake in American Vanguard during the 4th quarter worth approximately $1,751,000. EVR Research LP lifted its stake in American Vanguard by 82.0% in the fourth quarter. EVR Research LP now owns 618,657 shares of the basic materials company’s stock worth $2,363,000 after acquiring an additional 278,657 shares during the last quarter. Gamco Investors INC. ET AL acquired a new position in American Vanguard during the 4th quarter worth approximately $229,000. Williams & Novak LLC increased its position in shares of American Vanguard by 97.1% in the 4th quarter. Williams & Novak LLC now owns 30,230 shares of the basic materials company’s stock valued at $115,000 after purchasing an additional 14,895 shares during the last quarter. Finally, BlackRock Inc. acquired a new stake in shares of American Vanguard in the 2nd quarter valued at $2,614,000. Institutional investors and hedge funds own 79.00% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Wall Street Zen cut American Vanguard from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Vanguard in a research note on Thursday, August 13th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

About American Vanguard

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.